Southcoast Childrens Theatre Incorporated

Follow Message Edit

To provide a theatre experience for the community

ICO

263182931

Facebook

Web

Sign in to see organisation website

Address

North Dartmouth

Address: 147 W Hawthorn St, North DartmouthWeb: Sign in to see organisation websiteRevenue: 53115ICO: 263182931

News & Updates XX

From Social media

News about from their social media (Facebook and X).

Collected information

Data about organisation

North Dartmouth

Organisations from Southcoast Childrens Theatre Incorporated

More from North Dartmouth

Interesting nearby

Interesting organisations close by to residence of Southcoast Childrens Theatre Incorporated

CAPE COD THEATRE PROJECT INC

We develop new plays for the American Theater.

On Stage Theatrical Productions Inc

On Stage Theatrical Productions,Inc.

More Interesting nearby
Join us

Join us and make a difference for the future!

A brilliant resource for anyone who wants to do good more effectively.

Brooklyn Simmons
Janet

Simple interface, deep purpose. Eduo makes it easy for everyday people to become part of a global community doing good.

Brooklyn Simmons
Eve

Transparent, useful, and beautifully designed.

Brooklyn Simmons
Catherine

Eduo connects you to causes that actually matter to you.

Brooklyn Simmons
Michelle

As a teacher, I use Eduo in class to show students how civic engagement works. It’s inspiring and educational. Highly recommend for schools and community groups.

Brooklyn Simmons
Pamela

Clean, community-driven, and full of heart — love it.

Brooklyn Simmons
William
Sign Up

Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)

Sign in with Google
Or
Collected information

Good News

Peter 2025-10-24

SEALSQ Announces Uplisting to NASDAQ Global Select Market; Reaches $1 Billion Market Capitalization

StreetInsider.com

Like Comment
Monika 2025-10-24

Would A New Diagnosis Of Profound Autism Help Autistic People?

Forbes

Like Comment
Aneta 2025-10-24

Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference - Fortress Biotech (NASDAQ:FBIO), Journey Medical (NASDAQ:DERM)

Benzinga

Like Comment